Trial Outcomes & Findings for Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty (NCT NCT03457116)

NCT ID: NCT03457116

Last Updated: 2021-11-23

Results Overview

Pain scores are reported via Post-Operative Pain Management Survey. On a scale of 1-10, participants indicate how much pain they were in on their pain regiment. The higher the score, the worse the pain (1 = no pain, 10 = worst pain possible)

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

70 participants

Primary outcome timeframe

Day 0

Results posted on

2021-11-23

Participant Flow

Participant milestones

Participant milestones
Measure
NSAIDS
400mg of Ibuprofen NSAID: Ibuprofen 400mg for post-operative pain
Opiates
Norco (hydrocodone 5mg- acetaminophen 325mg) Norco: 20 tablets of Hydrocodone 5mg-Acetaminophen 325mg (Norco)
Overall Study
STARTED
41
29
Overall Study
COMPLETED
41
29
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
NSAIDS
n=41 Participants
400mg of Ibuprofen NSAID: Ibuprofen 400mg for post-operative pain
Opiates
n=29 Participants
Norco (hydrocodone 5mg- acetaminophen 325mg) Norco: 20 tablets of Hydrocodone 5mg-Acetaminophen 325mg (Norco)
Total
n=70 Participants
Total of all reporting groups
Age, Continuous
32 years
n=5 Participants
32 years
n=7 Participants
32 years
n=5 Participants
Sex: Female, Male
Female
19 Participants
n=5 Participants
12 Participants
n=7 Participants
31 Participants
n=5 Participants
Sex: Female, Male
Male
22 Participants
n=5 Participants
17 Participants
n=7 Participants
39 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
White
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
41 Participants
n=5 Participants
29 Participants
n=7 Participants
70 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Day 0

Pain scores are reported via Post-Operative Pain Management Survey. On a scale of 1-10, participants indicate how much pain they were in on their pain regiment. The higher the score, the worse the pain (1 = no pain, 10 = worst pain possible)

Outcome measures

Outcome measures
Measure
NSAIDS
n=41 Participants
400mg of Ibuprofen NSAID: Ibuprofen 400mg for post-operative pain
Opiates
n=29 Participants
Norco (hydrocodone 5mg- acetaminophen 325mg) Norco: 20 tablets of Hydrocodone 5mg-Acetaminophen 325mg (Norco)
Average Pain Score
2.54 score on a scale
Standard Deviation 1.57
3.14 score on a scale
Standard Deviation 1.75

PRIMARY outcome

Timeframe: Day 1

Pain scores are reported via Post-Operative Pain Management Survey. On a scale of 1-10, participants indicate how much pain they were in on their pain regiment. The higher the score, the worse the pain (1 = no pain, 10 = worst pain possible)

Outcome measures

Outcome measures
Measure
NSAIDS
n=41 Participants
400mg of Ibuprofen NSAID: Ibuprofen 400mg for post-operative pain
Opiates
n=29 Participants
Norco (hydrocodone 5mg- acetaminophen 325mg) Norco: 20 tablets of Hydrocodone 5mg-Acetaminophen 325mg (Norco)
Average Pain Score
1.84 score on a scale
Standard Deviation 1.29
2.46 score on a scale
Standard Deviation 1.90

PRIMARY outcome

Timeframe: Day 7

Pain scores are reported via Post-Operative Pain Management Survey. On a scale of 1-10, participants indicate how much pain they were in on their pain regiment. The higher the score, the worse the pain (1 = no pain, 10 = worst pain possible)

Outcome measures

Outcome measures
Measure
NSAIDS
n=41 Participants
400mg of Ibuprofen NSAID: Ibuprofen 400mg for post-operative pain
Opiates
n=29 Participants
Norco (hydrocodone 5mg- acetaminophen 325mg) Norco: 20 tablets of Hydrocodone 5mg-Acetaminophen 325mg (Norco)
Average Pain Score
3.29 score on a scale
Standard Deviation 2.14
3.14 score on a scale
Standard Deviation 2.12

PRIMARY outcome

Timeframe: Day 7

Self-reported via Post-Operative Pain Management Survey

Outcome measures

Outcome measures
Measure
NSAIDS
n=41 Participants
400mg of Ibuprofen NSAID: Ibuprofen 400mg for post-operative pain
Opiates
n=29 Participants
Norco (hydrocodone 5mg- acetaminophen 325mg) Norco: 20 tablets of Hydrocodone 5mg-Acetaminophen 325mg (Norco)
Average Post-Operative Day (POD) of Medication Cessation
4.73 days
Standard Deviation 1.57
4.28 days
Standard Deviation 2.23

SECONDARY outcome

Timeframe: Day 7

Population: This outcome measure is only applicable to NSAIDS

Outcome measures

Outcome measures
Measure
NSAIDS
n=41 Participants
400mg of Ibuprofen NSAID: Ibuprofen 400mg for post-operative pain
Opiates
Norco (hydrocodone 5mg- acetaminophen 325mg) Norco: 20 tablets of Hydrocodone 5mg-Acetaminophen 325mg (Norco)
Number of Participants in NSAIDs Group Who Were Upgraded to Opiates Due to High Levels of Pain
5 Participants

Adverse Events

NSAIDS

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Opiates

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Judy Lee, MD

NYU Langone Health

Phone: (646) 501-7906

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place